课题基金 / 基金详情

Translating targeted next-generation sequencing into a clinical tool for personalized management of squamous cell lung cancer

Translating targeted next-generation sequencing into a clinical tool for personalized management of squamous cell lung cancer
将靶向下一代测序转化为鳞状细胞肺癌个性化管理的临床工具
批准号：
302457
负责人：
Sacher Adrian G
金额：
$0.0万
依托单位：
Dana-Farber Cancer Institute (Boston)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-11-01 至 2014-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=302457&lang=en
关键词：
Non-Small Cell Lung Cancer Personalized Medicine Squamous Cell Lung Carcinoma Targeted Next-Generation Sequencing Targeted Therapy

项目摘要

项目成果

Sacher Adrian G的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung cancer is the leading cause of cancer-related death in Canada. The treatment of the most common type of lung cancer known as adenocarcinoma has been greatly improved by the recent development of new treatments that target specific genetic mutations i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mucosal Associated Invariant T-cells (MAIT cells) as Key Mediators of Anti-Tumor Immune Responses and the Microbiome Effect in Non-Small Cell Lung Cancer (NSCLC)
  • 批准号：
    409612
  • 项目类别：
    Operating Grants
  • 资助金额：
    $20.62万
  • 财政年份：
    2019
  • 负责人：
    Sacher Adrian G
  • 依托单位：
    University Health Network (Toronto)
Quantitative Plasma Genotyping as a Biomarker of Treatment Response in Advanced NSCLC
  • 批准号：
    318940
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $4.37万
  • 财政年份：
    2014
  • 负责人：
    Sacher Adrian G
  • 依托单位：
    Dana-Farber Cancer Institute (Boston)
海外基金